PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Wuxi People\'s Hospital Attached to Nanjing Medical University, Wuxi 214023, Jiangsu, China.\', \'Research Department, Wuxi Maternal and Child Health Hospital Attached to Nanjing Medical University, Wuxi 214002, Jiangsu, China.\', \'Center of Clinical Research, Wuxi People\'s Hospital Attached to Nanjing Medical University, Wuxi 214023, Jiangsu, China.\', \'Lung Transplant Center, Wuxi People\'s Hospital Attached to Nanjing Medical University, Wuxi 214023, Jiangsu, China.\', \'Department of Pharmacy, Wuxi People\'s Hospital Attached to Nanjing Medical University, Wuxi 214023, Jiangsu, China. Electronic address: qizhigang058518@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(20)31418-110.1016/j.intimp.2020.106749
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32645632
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32645632>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32645632>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all